In vivo and in vitro effects of QHF combined with chemotherapy on hepatocellular carcinoma

Qin, 2006, Development in Primary Carcinoma of the Liver-Hong Kong-Shanghai International Liver Congress 2006 Summary, Chinese J Surg (In Chinese), 44, 1070 Huo, 2005, Percutaneous ablation therapy for hepatocellular carcinoma: current practice and future perspectives, J Chin Med Assoc (In Chinese), 68, 155, 10.1016/S1726-4901(09)70239-4 Ebara, 2005, Percutaneous ethanol injection for small hepatocellular carcinoma: Therapeutic efficacy based on 20-year observation, J Hepatol, 43, 458, 10.1016/j.jhep.2005.03.033 Chan, 2007, Duodeno pleural fistula formation after percutaneous radiofrequency ablation for recurrent hepatocellular carcinoma, Asian J Surg, 30, 278, 10.1016/S1015-9584(08)60039-1 Francica, 1999, Ultrasound-guided percutaneous treatment of hepatocellular carcinoma by radiofrequency hyperthermia with a "cooled-tip needle". A preliminary clinical experience, Eur J Ultrasound, 9, 145, 10.1016/S0929-8266(99)00022-1 Fontana, 2002, Percutaneous radiofrequency thermal ablation of hepatocellular carcinoma: A safe and effective bridge to liver transplantation, Liver Transpl, 8, 1165, 10.1053/jlts.2002.36394 Momeny, 2008, Effects of silibinin on cell growth and invasive properties of a human hepatocellular carcinoma cell line, HepG-2, through inhibition of extracellular signal-regulated kinase 1/2 phosphorylation, Eur J Pharmacol, 591, 13, 10.1016/j.ejphar.2008.06.011 Jasinghe, 2008, ABT-869, a multi-targeted tyrosine kinase inhibitor, in combination with rapamycin is effective for subcutaneous hepatocellular carcinoma xenograft, J Hepatol, 49, 985, 10.1016/j.jhep.2008.08.010 Liu, 2007, Blockage of epidermal growth factor receptor by quinazoline tyrosine kinase inhibitors suppresses growth of human hepatocellular carcinoma, Cancer Lett, 248, 32, 10.1016/j.canlet.2006.05.018 Höpfner, 2004, Targeting the epidermal growth factor receptor by gefitinib for treatment of hepatocellular carcinoma, J Hepatol, 41, 1008, 10.1016/j.jhep.2004.08.024 Ma, 2007, Complete eradication of hepatocellular carcinomas by combined vasostatin gene therapy and B7H3-mediated immunotherapy, J Hepatol, 46, 98, 10.1016/j.jhep.2006.07.031 Zhang, 2008, Immunotherapy of hepatocellular carcinoma with a vaccine based on xenogeneic homologous α fetoprotein in mice, Biochem Biophys Res Commun, 376, 10, 10.1016/j.bbrc.2008.08.061 Gish, 2008, Hepatocellular carcinoma (HCC): Current and evolving therapies, Drugs, 11, 198 Lencioni, 2008, Image-guided thermal ablation of hepatocellular carcinoma, Crit Rev Oncol Hematol, 66, 201, 10.1016/j.critrevonc.2008.01.003 Llovet, 2008, Novel advancements in the management of hepatocellular carcinoma in 2008, J Hepatol, 48, S20, 10.1016/j.jhep.2008.01.022 Liapi, 2007, Transcatheter arterial chemoembolization: current technique and future promise, Tech Vasc Interv Radiol, 10, 2, 10.1053/j.tvir.2007.08.008 Cheng, 2007, RNA interference targeting HBx suppresses tumor growth and enhances cisplatin chemosensitivity in human hepatocellular carcinoma, Cancer Lett, 253, 43, 10.1016/j.canlet.2007.01.004 Tse, 2008, Conformal radiotherapy for hepatocellular carcinoma, Crit Rev Oncol Hematol, 67, 113, 10.1016/j.critrevonc.2008.01.005 Peng, 2008, Risk factors of survival after percutaneous radiofrequency ablation of hepatocellular carcinoma, Surgical Oncology, 17, 23, 10.1016/j.suronc.2007.08.002 Lam, 2008, Risk factors and prognostic factors of local recurrence after radiofrequency ablation of hepatocellular carcinoma, J Am Coll Surg, 207, 20, 10.1016/j.jamcollsurg.2008.01.020 Xu, 2005, Prognostic factors for long-term outcome after percutaneous thermal ablation for hepatocellular carcinoma: a survival analysis of 137 consecutive patients, Clin Radiol, 60, 1018, 10.1016/j.crad.2005.04.009 Liao, 2002, Prognosis of small hepatocellular carcinoma treated by percutaneous ethanol injection and transcatheter arterial chemoembolization, J Clin Epidemiol, 55, 1095, 10.1016/S0895-4356(02)00487-0 Wang, 2006, Methodology and Prospects of Study on Theory of Compatibility of Prescriptions in Traditional Chinese Medicine, World Science and Technology-Modernization of Traditional Chinese Medicine and Materia Medica, 8, 1 Wang, 2006, Study on combination components and effectiveness of Chinese traditional herbal formulas, China J Chinese Materia Medica (In Chinese), 31, 5 Chen, 2008, Screening of QHF formula for effective ingredients from Chinese herbs and its anti-hepatic cell cancer effect in combination with chemotherapy, Chin Med J (In Chinese), 121, 363, 10.1097/00029330-200802020-00015 Du, 2002, Studies of Chinese medicine compound active ingredient group, Proprietary Chin Med (In Chinese), 24, 878 Zou, 2005, Molecular mechanisms of anti-tumor progress, List of foreign medical oncology credits in, 32, 17 Vermes, 2000, Flow cytometry of apoptotic cell death, J Immunol Methods, 243, 167, 10.1016/S0022-1759(00)00233-7 Williams, 2004, Flow cytometry-based methods for apoptosis detection in lymphoid cells, Methods Mol Biol, 282, 31